Topic: LILLY
93 results were found.
Philip Johnson to retire as Lilly treasurer - February 12, 2024
Eli Lilly to offer low cost insulin, donate to clinics in Minnesota settlement - February 9, 2024
Eli Lilly Q4 profit $2.19 billion - February 6, 2024
Eli Lilly to acquire POINT Biopharma in $1.4b deal - October 4, 2023
Eli Lilly Q2 profit up - August 9, 2023
Eli Lilly will acquire Versanis for up to $1.925 billion - July 17, 2023
EVA Pharma completes new biologics facility as part of insulin collaboration with Eli Lilly - June 6, 2023
Eli Lilly to invest additional $1.6 bln, commits 200 new jobs - April 18, 2023
Roche announces collaboration with Eli Lilly to enhance early diagnosis of Alzheimer's disease - March 23, 2023
Eli Lilly and IABL to ensure patient access to high-quality affordable insulin in Bangladesh - February 14, 2023
Eli Lilly Q4 profit $1.94 billion - February 2, 2023
Eli Lilly to invest $450 mln more to expand capacity - January 25, 2023
FDA bans Eli Lilly, Regeneron antibody use in COVID-19 patients infected by omicron - December 1, 2022
Eli Lilly loses $15 billion after fake account's 'insulin is free' tweet - November 12, 2022
Eli Lilly Q3 revenue $6.94 billion - November 2, 2022
Eli Lilly plans to invest $2.1 billion in new manufacturing sites in Indiana - May 26, 2022
Eli Lilly Q1 net income increased 40 percent - April 29, 2022
Eli Lilly to halt exports of non-essential medicines to Russia - March 16, 2022
Eli Lilly announces Institute for Genetic Medicine and $700 million investment in Boston Seaport site - February 25, 2022
Eli Lilly to supply up to 600,000 doses of COVID-19 drug candidate to U.S. - February 11, 2022
Eli Lilly Q4 net income $1.73 billion - February 4, 2022
Eli Lilly to create nearly 600 jobs in Cabarrus County, North Carolina - February 1, 2022
EMA ended rolling review of bamlanivimab and etesevimab developed by Elli Lilly Netherlands - November 3, 2021
Eli Lilly Q3 earnings $1.11 billion - October 26, 2021
Eli Lilly to supply up to 220,000 doses of its COVID-19 antibody combo to EU - September 22, 2021
U.S. FDA seeks new warnings on drugs from Pfizer, Lilly and AbbVie - September 2, 2021
Eli Lilly Q2 net income fell 2 percent - August 3, 2021
U.S. pauses use of Eli Lilly COVID-19 mAb combo in six more states due to variants from Brazil, India - June 26, 2021
Eli Lilly Q1 profit down 7% - April 27, 2021
Eli Lilly is seeking an EUA for bamlanivimab and etesevimab together from FDA as COVID treatment - April 16, 2021
First of its kind: Eli Lilly's ulcerative colitis treatments completes Phase 3 study - March 16, 2021
EMA starts rolling review of Eli Lilly COVID-19 antibodies treatment - March 12, 2021
Eli Lilly names two executives - March 9, 2021
Eli Lilly partners with Area Health Systems on important antibody infusion therapies for COVID-19 - February 1, 2021
Eli Lilly Q4 revenue $7.440 billion - January 30, 2021
U.S. group seeks more data on Eli Lilly coronavirus drug - November 13, 2020
Eli Lilly pauses antibody trial over safety concerns - October 14, 2020
Eli Lilly says antibody drug cuts coronavirus hospitalization - September 17, 2020
Eli Lilly starts phase 3 trial of antibody treatments against coronavirus in care facilities - August 5, 2020
Lilly begins phase 3 clinical trial with baricitinib for hospitalized coronavirus patients - June 19, 2020
Eli Lilly and Company announced financial results for the first quarter of 2020. - April 23, 2020
Eli Lilly and Company Q4 revenue $6.114 billion - January 30, 2020
Eli Lilly selects North Carolina for plant, creates 460 jobs - January 23, 2020
Eli Lilly to acquire Dermira for $1.1 billion - January 10, 2020
Eli Lilly and Company Q3 revenue $5.477 billion - October 23, 2019
Eli Lilly Q1 adjusted net income decreased 4 percent - April 30, 2019
Eli Lilly Q4 revenue $6.439 billion - February 6, 2019
Lilly to buy Loxo Oncology in $8 billion deal - January 7, 2019
Eli Lilly and Company Q3 revenue $6.062 billion - November 6, 2018
Eli Lilly and Company elects Karen Walker to board - October 17, 2018
Eli Lilly and Company Q2 revenue up 9 percent - July 24, 2018
Eli Lilly completes acquisition of ARMO BioSciences - June 25, 2018
Lilly to buy cancer drug developer AurKa Pharma for up to $575 million - May 15, 2018
Lilly to acquire ARMO BioSciences for $1.6 billion - May 11, 2018
Eli Lilly Q1 revenue increased 9 percent - April 25, 2018
Eli Lilly and Company appoints Maura Dickler as vice president - March 12, 2018
Eli Lilly and Company appoints Philip Johnson as vice president, finance - November 15, 2017
Eli Lilly to cut approximately 3,500 jobs - September 8, 2017
Eli Lilly and Company Q2 revenue $5.824 billion - July 25, 2017
Eli Lilly and Company appoints Leigh Ann Pusey as SVP - May 11, 2017
Eli Lilly and Co. reported Q1 loss - April 26, 2017
Eli Lilly & Co. to invest $850m in U.S. operations - March 24, 2017
Eli Lilly and Co. adds Carolyn R. Bertozzi to board - February 10, 2017
Eli Lilly and Co. Q4 profit increased 61 percent - January 31, 2017
Eli Lilly to acquire CoLucid Pharmaceuticals for $960m - January 18, 2017
Court says Eli Lilly may block Teva's generic - January 12, 2017
Eli Lilly & Co. expands immuno-oncology collaboration with Merck - January 11, 2017
Eli Lilly and Company sets capex at $1 billion, EPS to $2.67 - December 15, 2016
Eli Lilly and Company Q3 profit declines 2% - October 25, 2016
Eli Lilly names Joshua Smiley SVP, finance and treasurer - August 11, 2016
John C. Lechleiter to retire as Lilly CEO, David A. Ricks successor - July 28, 2016
Aarti Shah named chief information officer of Eli Lilly - June 14, 2016
Eli Lilly and Company expects EPS to be up to $2.33 - January 6, 2016
Juan R. Luciano elected to Lilly board of directors - December 16, 2015
Eli Lilly to expand Indianapolis R&D headquarters - November 3, 2015
Eli Lilly revenue increased 2 percent - October 23, 2015
Eli Lilly to expand in New York, create 50 jobs - October 10, 2015
Orthofix adds Lilly Marks to board of directors - June 28, 2015
Lilly promotes Darren J. Carroll to SVP, corporate business development - January 6, 2015
Novartis completes divestment of Animal Health business to Eli Lilly for $5.4 billion - January 5, 2015
Marschall S. Runge elected to Lilly board of directors - August 29, 2013
Lilly: Derica W. Rice acting chief executive officer - May 16, 2013
Eli Lilly and Co. CEO John C. Lechleiter to take medical leave - May 10, 2013
William G. Kaelin Jr. elected to Lilly board of directors - June 4, 2012
Eli Lilly promotes Derica Rice to executive vice president - December 18, 2009
Eli Lilly: Steven M. Paul to retire, Jan M. Lundberg successor - November 13, 2009
Bart Peterson to join Lilly leadership team - June 5, 2009
R. David Hoover elected to Eli Lilly board of directors - June 2, 2009
Lilly names Susan Mahony SVP of Human Resources - April 17, 2009
Eli Lilly: J. Michael Cook to retire, Michael Eskew to replace Mr. Cook - April 8, 2009
Eli Lilly's Anthony Murphy announces retirement - March 4, 2009
Eli Lilly: Alex M. Azar II to lead Lilly USA B2B operations - March 2, 2009
Enrique Conterno promoted to president, Lilly USA, LLC - January 30, 2009